THE STORY OF INDIAN PHARMA AND BIOTECH - BOOKS TO READ

For all those who are interested in the recent history of the pharmaceutical and biotechnology industry in India, and who want to go beyond annual reports and corporate presentations, four recently published biographies are must-reads.

Whereas the first and the last two books are autobiographies, ‘Myth Breaker’ is the result of countless interviews of key players (scientists, current and past coworkers, pharma rivals, ministries, etc…) by Seema Singh, thereby giving unique insights into the development of biotechnology in India:

  • An Unfinished Agenda - My Life in the Pharmaceutical Industry
    by K. Anji Reddy - former founder-chairman of Dr. Reddy's Laboratories
    Penguin Books, 2015 (270 pages)
    Click here for a review

  • Myth Breaker - Kiran Mazumdar-Shaw and the Story of Indian Biotech
    by Seema Singh - a renowned Indian journalist who writes on science and technology
    Harper Collins Publishers, 2016 (324 pages)
    Click here for a review

  • Taking Wings and Winning - Learning from Nurturing a Life Sciences Company from Inception
    by K. V. Subramaniam - President of Reliance Life Sciences Pvt. Ltd.
    Rupa Publications India, 2016 (230 pages)
    Click here for a review

  • Odyssey of Courage - The Story of an Indian Multinational
    by Habil Khorakiwala - Chairman Wockhardt Limited
    Rupa Publications India, 2017 (225 pages)
    Click here for a review

For those who are interested in the science of new drug discovery at Indian pharma and biotech companies, please refer to our recent review article “The Drug Discovery and Development Industry in India - Two Decades of Proprietary Small-Molecule R&D”

Available Open Access at http://onlinelibrary.wiley.com/doi/10.1002/cmdc.201700043/abstract

More information on current drug discovery efforts, both in the areas of NCES and NBs, are available from:

Edmond Differding, Ph.D.
Managing Director
Differding Consulting s.p.r.l.
Route de Blocry 55
B-1348 Louvain-la-Neuve
Belgium
Email: edmond@differding.com
Mobile: +32-474-41.24.64


 

LATEST NEWS

02.06.2017 | THE DRUG DISCOVERY AND DEVELOPMENT INDUSTRY IN INDIA - TWO DECADES OF PROPRIETARY SMALL-MOLECULE R&D

A comprehensive survey of proprietary drug discovery and development efforts by Indian companies between 1994 and mid-2016, focusing on preclinical and clinical development compounds by company, therapeutic indication, mode of action, target class, and development status. The analysis includes the evolution of the overall pipeline over two decades, attrition rates, in-house developments and contributions to Western pharmaceutical pipelines through licensing agreements.

AVAILABLE OPEN ACCESS

28.01.2018 | THE STORY OF INDIAN PHARMA AND BIOTECH - BOOKS TO READ

For all those who are interested in the recent history of the pharmaceutical and biotechnology industry in India, and who want to go beyond annual reports and corporate presentations, four recently published biographies are must-reads. Whereas three books are autobiographies, a fourth one is the result of countless interviews of key players (scientists, current and past coworkers, pharma rivals, ministries, etc…), and gives unique insights into the development of biotechnology in India.

READ MORE